Medical specialists from Greece tagged as investigators in clinical trials studying Severe Acute Respiratory Syndrome

Total 4 results

Athanasios Skoutelis
Seen in:
- Athens, Evangelismos General Hospital
Trials:
- NCT01056185 (Principal Investigator)
Conditions:
Helen Sambatakou, MD, PhD
Seen in:
- Athens, Hippokration University General Hospital of Athens
Trials:
- NCT01056185 (Principal Investigator)
Conditions:
Ioannis Kalomenidis
Seen in:
- Athens, 1st Dept of Critical Care Medicine and Pulmonary Services, Evangelismos Hospital
Trials:
- NCT01056185 (Principal Investigator)
Conditions:
Nikolaos Koulouris
Seen in:
- Athens, 1st Respiratory Medicine Dept, Athens Hosp for Diseases of the Chest "Sotiria Hospital"
Trials:
- NCT01056185 (Principal Investigator)
Conditions:

Clinical Trials on Severe Acute Respiratory Syndrome

Assistance Publique - Hôpitaux de Paris

Completed

Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS (STROMA-CoV2)

Severe Acute Respiratory Syndrome Coronavirus 2 | Severe Acute Respiratory Distress Syndrome

France
Oneness Biotech Co., Ltd.

Completed

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants

Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)

United States
NeuroActiva, Inc.

Unknown

Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831 (NEUROSIVIR)

Severe Acute Respiratory Syndrome | Covid19 | Corona Virus Infection | Severe Acute Respiratory Syndrome (SARS) Pneumonia | Neurodegeneration | Neuroinflammatory Response | Severe Acute Respiratory Infection | Severe Acute Respiratory Syndrome of Upper Respiratory Tract

United States
Hôpital Universitaire Sahloul

Completed

Quercetin In The Treatment Of SARS-COV 2 (QUERCOV)

SARS (Severe Acute Respiratory Syndrome)

Tunisia
Wits Health Consortium (Pty) Ltd
Fred Hutchinson Cancer Center; Janssen Vaccines & Prevention B.V.; National Institute... and other collaborators

Completed

Sisonke (Together): OPEN LABEL TRIAL COVID-19 (Sisonke)

SARS (Severe Acute Respiratory Syndrome)

South Africa
Laboratorios Silanes S.A. de C.V.

Completed

Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. (DMMETCOV19-2)

Severe Acute Respiratory Syndrome Coronavirus 2

Mexico
Takeda

Completed

A Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)

Japan
Throne Biotechnologies Inc.

Not yet recruiting

Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19

Severe Acute Respiratory Syndrome (SARS) Pneumonia
Massachusetts General Hospital
Xijing Hospital; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Niguarda...

Completed

Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 (NOSARSCOVID)

Coronavirus | SARS (Severe Acute Respiratory Syndrome)

United States, Sweden
University of Saskatchewan
Government of Canada; Vaccine Formulation Institute (VFI); Government of Saskatchewan and other collaborators

Completed

A Clinical Trial of COVAC-2 in Healthy Adults

Severe Acute Respiratory Syndrome Coronavirus 2

Canada

Medical specialists from Greece tagged as investigators in clinical trials studying Severe Acute Respiratory Syndrome

Clinical Trials on Severe Acute Respiratory Syndrome

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations